Does VALSARTAN Cause Chronic obstructive pulmonary disease? 205 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 205 reports of Chronic obstructive pulmonary disease have been filed in association with VALSARTAN (valsartan). This represents 0.9% of all adverse event reports for VALSARTAN.
205
Reports of Chronic obstructive pulmonary disease with VALSARTAN
0.9%
of all VALSARTAN reports
11
Deaths
83
Hospitalizations
How Dangerous Is Chronic obstructive pulmonary disease From VALSARTAN?
Of the 205 reports, 11 (5.4%) resulted in death, 83 (40.5%) required hospitalization, and 5 (2.4%) were considered life-threatening.
Is Chronic obstructive pulmonary disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALSARTAN. However, 205 reports have been filed with the FAERS database.
What Other Side Effects Does VALSARTAN Cause?
Drug ineffective (1,845)
Blood pressure increased (1,682)
Dizziness (1,527)
Headache (1,361)
Hypertension (1,341)
Acute kidney injury (1,301)
Dyspnoea (1,239)
Fatigue (1,156)
Malaise (1,139)
Hypotension (1,032)
What Other Drugs Cause Chronic obstructive pulmonary disease?
ALBUTEROL (2,916)
TIOTROPIUM (2,895)
BUDESONIDE\FORMOTEROL (2,279)
FLUTICASONE\SALMETEROL (1,904)
ADALIMUMAB (1,712)
PREDNISONE (1,237)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145)
MEPOLIZUMAB (1,107)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967)
DUPILUMAB (907)
Which VALSARTAN Alternatives Have Lower Chronic obstructive pulmonary disease Risk?
VALSARTAN vs VALTREX
VALSARTAN vs VAMOROLONE
VALSARTAN vs VANCOMYCIN
VALSARTAN vs VANDETANIB
VALSARTAN vs VARDENAFIL